Literature DB >> 6838493

Immunological comparison of the usual and atypical human serum cholinesterase phenotypes.

H W Eckerson, A Oseroff, O Lockridge, B N La Du.   

Abstract

Antiserum prepared against highly purified usual human serum cholinesterase (the most common phenotype) cross-reacted identically with the atypical serum cholinesterase. The level of circulating atypical enzyme protein, determined immunologically, was about 30% lower when the enzyme came from an atypical rather than a usual phenotype, and the level of enzyme activity measured enzymatically at Vmax with either o-nitrophenylbutyrate or benzoylcholine as substrate showed approximately the same degree of reduction. The average specific activity (activity at Vmax per microgram of enzyme protein) in sera from 28 usual and 20 atypical individuals did not differ significantly. These findings suggest that the atypical enzyme not only has altered catalytic properties (Km) but also might be synthesized more slowly, or cleared in vivo more rapidly, than the usual enzyme.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6838493

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  43 in total

1.  THE CLINICAL STABILITY OF SERUM CHOLINESTERASE ACTIVITY.

Authors:  H J WETSTONE; R V LAMOTTA
Journal:  Clin Chem       Date:  1965-06       Impact factor: 8.327

2.  The action of normal and atypical cholinesterase of human serum upon a series of esters of choline.

Authors:  R O DAVIES; A V MARTON; W KALOW
Journal:  Can J Biochem Physiol       Date:  1960-06

3.  New allele at cholinesterase locus 1.

Authors:  P J Garry; A A Dietz; T Lubrano; P C Ford; K James; H M Rubinstein
Journal:  J Med Genet       Date:  1976-02       Impact factor: 6.318

4.  Physical separation of pseudocholinesterase variants in human serum.

Authors:  J LIDDELL; H LEHMANN; D DAVIES; A SHARIH
Journal:  Lancet       Date:  1962-03-03       Impact factor: 79.321

5.  Studies on cholinesterase. VII. The active surface of acetylcholine esterase derived from effects of pH on inhibitors.

Authors:  I B WILSON; F BERGMANN
Journal:  J Biol Chem       Date:  1950-08       Impact factor: 5.157

6.  A pseudocholinesterase variant (E Cynthiana) associated with elevated plasma enzyme activity.

Authors:  A Yoshida; A G Motulsky
Journal:  Am J Hum Genet       Date:  1969-09       Impact factor: 11.025

7.  Contribution of hereditary factors to the response to drugs.

Authors:  W Kalow
Journal:  Fed Proc       Date:  1965 Nov-Dec

8.  Prediction of drug sensitivity in individuals with atypical serum cholinesterase based on in vitro biochemical studies.

Authors:  R J Valentino; O Lockridge; H W Eckerson; B N La Du
Journal:  Biochem Pharmacol       Date:  1981-06-15       Impact factor: 5.858

9.  Cholinesterase Newfoundland: a new succinylcholine-sensitive variant of cholinesterase at locus 1.

Authors:  N E Simpson; C R Elliott
Journal:  Am J Hum Genet       Date:  1981-05       Impact factor: 11.025

10.  Structural difference at the active site of dibucaine resistant variant of human plasma cholinesterase.

Authors:  H Muensch; A Yoshida; K Altland; W Jensen; H W Goedde
Journal:  Am J Hum Genet       Date:  1978-05       Impact factor: 11.025

View more
  5 in total

1.  DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites.

Authors:  C F Bartels; F S Jensen; O Lockridge; A F van der Spek; H M Rubinstein; T Lubrano; B N La Du
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

2.  Protandim does not influence alveolar epithelial permeability or intrapulmonary oxidative stress in human subjects with alcohol use disorders.

Authors:  Ellen L Burnham; Joe M McCord; Swapan Bose; Lou Ann S Brown; Robert House; Marc Moss; Jeanette Gaydos
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-20       Impact factor: 5.464

3.  Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing.

Authors:  B N La Du; C F Bartels; C P Nogueira; M Arpagaus; O Lockridge
Journal:  Cell Mol Neurobiol       Date:  1991-02       Impact factor: 5.046

4.  Cholinesterase variants: rapid characterisation by PCR/SSCP and evidence for molecular homogeneity.

Authors:  T Höhler; M Hundt; C Rittner; P M Schneider; K H Meyer zum Büschenfelde
Journal:  J Med Genet       Date:  1995-02       Impact factor: 6.318

Review 5.  Naturally Occurring Genetic Variants of Human Acetylcholinesterase and Butyrylcholinesterase and Their Potential Impact on the Risk of Toxicity from Cholinesterase Inhibitors.

Authors:  Oksana Lockridge; Robert B Norgren; Rudolph C Johnson; Thomas A Blake
Journal:  Chem Res Toxicol       Date:  2016-08-31       Impact factor: 3.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.